Discover 1,825 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,825
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
for
Colitis, Ulcerative
Location: Chapel Hill NC, Charlotte NC, Charleston SC,
Sponsor: Pfizer
Sex: All
Age: 18 - 64
Code: NCT06398626
Recruiting
The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
for
Kidney Transplant; Complications
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill
Location: Chapel Hill NC, Durham NC, Chattanooga TN, Columbus OH,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07294170
Recruiting
Advancing Identification of Circadian Delay in ADHD Youth: Associations With Clinical Heterogeneity and Cognition
for
ADHD - Attention Deficit Disorder With Hyperactivity, ADHD
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 6 - 9
Code: NCT06971640
Recruiting
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
for
Breast Cancer, Breast Cancer Metastatic,
Location: Durham NC, Charlotte NC, Augusta GA, Atlanta GA,
Sponsor: Incyclix Bio
Sex: All
Age: 18+
Code: NCT05735080
Phase 1, Phase 2, Recruiting
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Chapel Hill NC, Charlottesville VA, Fairfax VA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06385080
Phase 1, Phase 2, Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: Chapel Hill NC, Durham NC, Roanoke VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT03486873
Phase 3, Recruiting
BE WELL With Migraine: Brain Education and WELLness With Migraine
for
Migraine
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT05987592
Recruiting
Featured
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
for
Breast Reconstruction
Location: Winston-Salem NC, Johnson City TN, Baltimore MD,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06575192
Phase 3, Recruiting
Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis
Location: Chapel Hill NC, Charlottesville VA, Chicago IL, Calgary,
Sponsor: argenx
Sex: All
Age: 2 - 18
Code: NCT04833894
Phase 2, Phase 3, Recruiting
Onyx™ Liquid Embolic IDE Clinical Study
for
Peripheral Arterial Hemorrhage, Trauma, GI Bleed, Ulcer,
Location: Chapel Hill NC, Pittsburgh PA, Columbus OH,
Sponsor: Medtronic Endovascular
Sex: All
Age: 22+
Code: NCT06742801
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Chapel Hill NC, Durham NC, Charleston SC,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701669
Phase 2, Recruiting
Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy
for
Immunosuppression
Location: Durham NC
Sponsor: Linda Cendales
Sex: All
Age: 18 - 65
Code: NCT02310867
Phase 2, Recruiting
GRID Therapy for Extremity Soft Tissue Sarcoma
for
Sarcoma
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06073067
Recruiting
Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone
for
Peripheral Arterial Diseases
Location: Chapel Hill NC, Greenville SC, Baltimore MD,
Sponsor: Angiodynamics, Inc.
Sex: All
Age: 0+
Code: NCT06777901
Recruiting
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors